US Biopharma ‘Consortium’ Promises Array Of Coronavirus Remedies

Trump Administration officials pledge support for basic science and expedited regulatory review while emphasizing the benefits that could be offered by drugs in the near term until a vaccine is developed.

White House
Biopharma At White House Meeting On Coronavirus

A group of biopharma industry executives previewed several approaches to treatments and vaccines to combat COVID-19 at a meeting with President Trump and members of the White House Coronavirus Task Force at the White House on 2 March.

Officials also urged the companies to work collaboratively in the broader public interest. “I want to commend each and every...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet